Observations of disrupted IGF-1 signaling in AD patients, characterized by a reduced active/inactive IGF-1 ratio and elevated IGF-1R expression, prompted Selles et al. to explore the neuroprotective potential of IGF-1. Here, IGF1 is linked to Alzheimer disease.